MTOR and cancer: However, aberrant activation of this pathway, such as those associated with mammalian target of rapamycin (mTOR), is observed in various cancers, leading to uncontrolled protein synthesis and the subsequent transformation of normal cells to more aggressive cancerous cells [14, 15].